CLOs on the Move

Marathon Asset Management

www.marathonfund.com

 
Marathon Asset Management, L.P. is an investment manager focused on opportunistic investing in credit and fixed income markets globally. Marathon manages a family of investment programs principally focused on credit strategies including hedge funds, managed accounts, single-client funds and collateralized loan, and debt obligation vehicles. The firm`s core competency is distressed and situational investing in the global credit and fixed income markets. Marathon utilizes a research-intensive approach, risk management discipline, and an integrated platform. In addition, the firm has the flexibility to invest across the capital structure, including securities, loans, and structured products. The firm is headquartered in New York ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details
Ausra Ragauskaite
Vice President- Legal Profile
Jamie Raboy
Chief Risk Officer Profile
Christine Chartouni
Chief Legal Officer and Chief Compliance Officer Profile

Similar Companies

Leuthold Weeden Capital Management

Leuthold Weeden Capital Management is a Minneapolis, MN-based company in the Financial Services sector.

Nuveen

Nuveen is one of the world`s largest asset managers` serving institutions` financial intermediaries and individual investors in more than 30 countries` providing investment expertise across the capital structure. In partnership with advisors and consultants` we create outcome-focused solutions that help investors achieve a more secure financial future. Recognized as a leader in income generation` alternative investments and responsible investing` Nuveen has award-winning capabilities that span both public and private asset classes. Our investment approach is fueled by diversity of thought and a network of specialized investment teams with independent processes and best-in-class expertise. As the investment manager of TIAA` we honor a 100-plus year legacy of service and innovation based on enduring principles established by John Nuveen and Andrew Carnegie. Inspired by their vision` backed by size and scale` and empowered by private ownership` we are uniquely positioned to contribute meaningful results -- for investors` communities` and the world we share.

Tailwind

Tailwind Capital is a leading private equity firm investing in growth-oriented middle market companies in the healthcare and business and communications services sectors. Tailwind partners with management teams to build businesses through organic growth, strategic acquisition, and operational improvement. The firm currently has over $1 billion under management. Representative Tailwind investments include VersaPharm (generic pharmaceuticals), Aircast (orthopedic devices), Freedom Innovations (prosthetic devices), TowerCo (wireless infrastructure), Archway (marketing logistics), and Trover Solutions (insurance services).

Millennium

Millennium is a global alternative investment management firm, founded in 1989, which manages $57.8 billion in assets. We seek to pursue a diverse array of investment strategies across industry sectors, asset classes, and geographies. Our four primary strategies are RV Fundamental Equity, Equities Arbitrage, Fixed Income Strategies, and Quantitative Strategies. Millennium was founded on the belief that innovation and results come from empowering talented, independent-minded individuals. To us, success is the combination of drive and discipline.

Harris and Harris

Harris and Harris Group, Inc. builds transformative companies from disruptive science. We leverage our core scientific expertise to be FIRST in identifying new technology trends, in accessing high quality science and intellectual property, in building management teams and in executing on early-stage business growth. Our PROVEN team has the unique ability to identify and diligence the network of discoveries that come from understanding science at the intersection of different scientific disciplines, with biology as a focus.  This places us at the center of the discoveries impacting some of the most important growth sectors of the economy, permitting us to build TRANSFORMATIVE companies. BIOLOGY+ is our distinctive approach.  We define BIOLOGY+ as investments in interdisciplinary life science companies where biology innovation is intersecting with innovations in areas such as electronics, physics, materials science, chemistry, information technology, engineering and mathematics.  We focus on this intersection because we believe interdisciplinary innovation will be required in order to address many of the life science challenges of the future.